Bausch + Lomb Corp (BLCO) stock price

Bausch + Lomb Corp (BLCO) is a Healthcare · Medical Instruments & Supplies company listed on NYSE. Price $16.96 (+1.13%), Market cap $5.74B, 52-week low–high $11.19 ~ $18.60.

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provide optical correction during healing. It also offers contact lens care products, eye vitamins, mineral supplements, and over-the-counter eye drops that address various conditions, such

Key metrics

Financial statements, price targets, institutional (13F) holdings and related news for Bausch + Lomb Corp are updated in real time on BlackAll Trade.

Bausch + Lomb Corp financial summary

Analyst outlook

Key ratios · profitability · growth

Frequently asked questions

What is the current Bausch + Lomb Corp (BLCO) stock price?

Bausch + Lomb Corp trades at $16.96 (+1.13%). Real-time quotes and charts are available on BlackAll Trade.

What is the Bausch + Lomb Corp (BLCO) market cap?

Bausch + Lomb Corp has a market cap of about $5.74B.

What does Bausch + Lomb Corp (BLCO) do?

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and inte